Company Name | Celltrion |
---|---|
Website | https://www.celltrion.com |
Snippet | Celltrion has shifted the pharmaceutical paradigm with outstanding biopharmaceutical products, Research and Development capabilities, and expertise. Learn more . |
Type | Public |
Owner | Celltrion Holdings Co., Ltd. (23.03%)Ion Investments B.V. (9.54%)National Pension Service (6.07%) |
Founded | 2002 |
Founder | Jung Jin Seo |
Revenue | ₩828,917 million (2017)[1] |
Website | www.celltrion.com/en |
Industry | Biopharmaceutical |
Products | Remsima™, Truxima™, Herzuma™, Biosimilar Drug |
linkedin.com/company/celltrion | |
Key people | Jung Jin Seo, Chairman Woo Sung Kee, CEO |
Net income | ₩403,181 million (2017)[1] |
size_range | 501 - 1000 |
Area served | Worldwide |
Headquarters | Yeonsu-gu, Incheon, South Korea |
Total assets | ₩3,255,319 million (2017)[1] |
Total equity | ₩2,522,076 million (2017)[1] |
Operating income | ₩517,385 million (2017)[1] |
Number of employees | 265 |
Celltrion is part of the South Korea company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us